Decision to register two patents for ACPi, an automated anticancer drug preparation device, and a second cylinder pump

We have applied for a priority review of Patent Registration on May 13, 2020 and applied for the "Injection preparation kit and injection preparation system including the same" in the name of the invention, and received a notice of registration decision.

Although it was selected as a Big 3 project and research funding has not been paid yet, we have applied for permission after completing the development of the manual ACPi Anyfusion V100 from July 2020, and the development of the semi-automatic ACPi and the automatic AACPi has also been conducted at the same time, and the design has been completed.

We plan to finish developing the semi-automatic ACPi within this year once the design is complete.

We are developing AACPi at the same time as the ACPi development, and the final AACPi development is aimed to be completed within the first quarter of next year.

Prior to the completion of development, we conducted a preliminary consultation to apply for an innovative medical device from the Ministry of Food and Drug Safety, and we would like to apply for an innovative medical device based on the data of this patent registration.

If we are designated as an innovative medical device, we will be able to obtain domestic approval early within one month through rapid examination, and at the same time, we will go through CE, PMDA (Japan), and FDA certification, and will actively enter the world step by step by 2023, and will be the automated market for anticancer drug preparation. We will do our best to achieve sales of more than 500 billion won($ 500M) by 2025 with our flagship products.

Based on the information obtained from supplying the cylinder pump to the market so far, we applied for a second patent for the cylinder pump on March 10, 2020, and applied for priority examination at the same time as the ACPi patent application, an automated anticancer drug preparation device. At the same time, registration was decided, and The validity period of the cylinder pump patent has been extended to 2030 and is guaranteed.

We would like to share the joy with our shareholders, and thank and congratulations for the hard work of the people involved in doing their best to file an application!

Thank you.